These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

501 related articles for article (PubMed ID: 8052857)

  • 1. Transformation of mammalian cells by constitutively active MAP kinase kinase.
    Mansour SJ; Matten WT; Hermann AS; Candia JM; Rong S; Fukasawa K; Vande Woude GF; Ahn NG
    Science; 1994 Aug; 265(5174):966-70. PubMed ID: 8052857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MAP kinase activation is essential for oncogenic transformation of NIH3T3 cells by Mos.
    Okazaki K; Sagata N
    Oncogene; 1995 Mar; 10(6):1149-57. PubMed ID: 7700641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of mitogen-activated protein kinase kinase (MAPKK) and its mutants in NIH 3T3 cells. Evidence that MAPKK involvement in cellular proliferation is regulated by phosphorylation of serine residues in its kinase subdomains VII and VIII.
    Seger R; Seger D; Reszka AA; Munar ES; Eldar-Finkelman H; Dobrowolska G; Jensen AM; Campbell JS; Fischer EH; Krebs EG
    J Biol Chem; 1994 Oct; 269(41):25699-709. PubMed ID: 7929275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radicicol suppresses transformation and restores tropomyosin-2 expression in both ras- and MEK-transformed cells without inhibiting the Raf/MEK/ERK signaling cascade.
    Kim PN; Jonasch E; Mosterman BC; Mier JW; Janssen RA
    Cell Growth Differ; 2001 Nov; 12(11):543-50. PubMed ID: 11714635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cot protooncoprotein activates the dual specificity kinases MEK-1 and SEK-1 and induces differentiation of PC12 cells.
    Hagemann D; Troppmair J; Rapp UR
    Oncogene; 1999 Feb; 18(7):1391-400. PubMed ID: 10050876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transfection of constitutively active mitogen-activated protein/extracellular signal-regulated kinase kinase confers tumorigenic and metastatic potentials to NIH3T3 cells.
    Welch DR; Sakamaki T; Pioquinto R; Leonard TO; Goldberg SF; Hon Q; Erikson RL; Rieber M; Rieber MS; Hicks DJ; Bonventre JV; Alessandrini A
    Cancer Res; 2000 Mar; 60(6):1552-6. PubMed ID: 10749122
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Constitutively active MAP kinase kinase (MEK1) stimulates SAP kinase and c-Jun transcriptional activity in U937 human leukemic cells.
    Franklin CC; Kraft AS
    Oncogene; 1995 Dec; 11(11):2365-74. PubMed ID: 8570188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative effects of insulin on the activation of the Raf/Mos-dependent MAP kinase cascade in vitellogenic versus postvitellogenic Xenopus oocytes.
    Chesnel F; Bonnec G; Tardivel A; Boujard D
    Dev Biol; 1997 Aug; 188(1):122-33. PubMed ID: 9245517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The JNK/SAPK activator mixed lineage kinase 3 (MLK3) transforms NIH 3T3 cells in a MEK-dependent fashion.
    Hartkamp J; Troppmair J; Rapp UR
    Cancer Res; 1999 May; 59(9):2195-202. PubMed ID: 10232608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The stress-activated protein kinase subfamily of c-Jun kinases.
    Kyriakis JM; Banerjee P; Nikolakaki E; Dai T; Rubie EA; Ahmad MF; Avruch J; Woodgett JR
    Nature; 1994 May; 369(6476):156-60. PubMed ID: 8177321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Constitutively active mutants of MAP kinase kinase (MEK1) induce growth factor-relaxation and oncogenicity when expressed in fibroblasts.
    Brunet A; Pagès G; Pouysségur J
    Oncogene; 1994 Nov; 9(11):3379-87. PubMed ID: 7936666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of recombinant Xenopus MAP kinase kinases mutated at potential phosphorylation sites.
    Gotoh Y; Matsuda S; Takenaka K; Hattori S; Iwamatsu A; Ishikawa M; Kosako H; Nishida E
    Oncogene; 1994 Jul; 9(7):1891-8. PubMed ID: 8208535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SCH 51344 inhibits ras transformation by a novel mechanism.
    Kumar CC; Prorock-Rogers C; Kelly J; Dong Z; Lin JJ; Armstrong L; Kung HF; Weber MJ; Afonso A
    Cancer Res; 1995 Nov; 55(21):5106-17. PubMed ID: 7585559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of the Raf-1/MAP kinase cascade is not sufficient for Ras transformation of RIE-1 epithelial cells.
    Oldham SM; Clark GJ; Gangarosa LM; Coffey RJ; Der CJ
    Proc Natl Acad Sci U S A; 1996 Jul; 93(14):6924-8. PubMed ID: 8692920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of a signaling pathway in cardiac muscle cells by active mitogen-activated protein kinase kinase.
    Thorburn J; Carlson M; Mansour SJ; Chien KR; Ahn NG; Thorburn A
    Mol Biol Cell; 1995 Nov; 6(11):1479-90. PubMed ID: 8589450
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple pathways for activation of MAP kinases.
    Mitra G; Weber M; Stacey D
    Cell Mol Biol Res; 1993; 39(5):517-23. PubMed ID: 8173594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rit, a non-lipid-modified Ras-related protein, transforms NIH3T3 cells without activating the ERK, JNK, p38 MAPK or PI3K/Akt pathways.
    Rusyn EV; Reynolds ER; Shao H; Grana TM; Chan TO; Andres DA; Cox AD
    Oncogene; 2000 Sep; 19(41):4685-94. PubMed ID: 11032018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Constitutively active mitogen-activated protein kinase kinase 1 (MAPKK1) and MAPKK2 mediate similar transcriptional and morphological responses.
    Mansour SJ; Candia JM; Gloor KK; Ahn NG
    Cell Growth Differ; 1996 Feb; 7(2):243-50. PubMed ID: 8822208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of the EGF-activated MAP kinase signaling pathway by adenosine 3',5'-monophosphate.
    Wu J; Dent P; Jelinek T; Wolfman A; Weber MJ; Sturgill TW
    Science; 1993 Nov; 262(5136):1065-9. PubMed ID: 7694366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Signaling pathways mediated by the mitogen-activated protein (MAP) kinase kinase/MAP kinase cascade.
    Matsuda S; Gotoh Y; Nishida E
    J Leukoc Biol; 1994 Nov; 56(5):548-53. PubMed ID: 7964162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.